Xencor (XNCR) FCF Margin (2013 - 2026)
Xencor (XNCR) posted quarterly FCF Margin of 1511.03% for Q1 2026, down 145706.0% year-over-year from N/an in Q1 2025, and down 707.31% quarter-over-quarter from 187.17% in Q4 2025.
Powered by 
Analysis
Xencor (XNCR) FCF Margin (2013 - 2026) Analysis & Trends
Xencor (XNCR) has reported FCF Margin for 14 consecutive years, with 1511.03% the latest figure, recorded in Q1 2026.
- In Q1 2026, FCF Margin fell 145706.0% year-over-year to 1511.03%; the TTM figure through Mar 2026 stood at 193.96% (down 6116.0% YoY), while the FY2025 annual figure was 110.11%, up 7840.0% from the prior year.
- FCF Margin fell to 1511.03% in Q1 2026 per XNCR's latest filing, from 187.17% in the prior quarter.
- Across five years, FCF Margin topped out at 105.68% in Q2 2022 and bottomed at 1511.03% in Q1 2026.
- Historically, FCF Margin has averaged 195.88% across 5 years, with a median of 97.55% in 2024.
- Annual changes were most pronounced in 2025 — FCF Margin jumped 30230 bps — and 2026, when it slumped 145706 bps.
- Xencor's FCF Margin stood at 159.17% in 2022, then jumped by 121 bps to 33.69% in 2023, then plunged by 390 bps to 97.55% in 2024, then slumped by 92 bps to 187.17% in 2025, then tumbled by 707 bps to 1511.03% in 2026.
- Business Quant data shows XNCR's FCF Margin at 1511.03% in Q1 2026, 187.17% in Q4 2025, and 147.63% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Xencor | 2.02 Bn | 1.65 Bn | - | -109.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -109.71% |
| Mar 31, 2026 | -1,511.03% |
| Dec 31, 2025 | -187.17% |
| Sep 30, 2025 | -147.63% |
| Jun 30, 2025 | -84.28% |
| Mar 31, 2025 | -53.97% |
| Dec 31, 2024 | -97.55% |
| Sep 30, 2024 | -165.30% |
| Jun 30, 2024 | -294.37% |
| Mar 31, 2024 | -356.26% |
| Dec 31, 2023 | 33.73% |
| Sep 30, 2023 | -50.87% |
| Jun 30, 2023 | -92.38% |
| Mar 31, 2023 | -217.88% |
| Dec 31, 2022 | -159.25% |
| Sep 30, 2022 | -55.87% |
| Jun 30, 2022 | 105.68% |
| Mar 31, 2022 | 4.36% |
| Dec 31, 2021 | 36.02% |
| Sep 30, 2021 | -212.02% |